Medical Innovation

Hospital Clinical Trials

Advancing Medical Science through Ethical and Evidence-Based Research.

About Hospital Clinical Trials

At DianaMik Hospital Management Consultancy LLP, we are committed to contributing to medical innovation through ethical, transparent, and patient-focused clinical trials.

Our Consultancy Clinical Trial team provides structured guidance & support for conducting clinical research that meets national and international ethical standards, including NABH, ICMR, ICH-GCP, and CDSCO guidelines.

Objectives of Clinical Trials

  • Evaluate the safety and efficacy of new drugs, devices, and treatments.
  • Generate scientific evidence that supports better patient outcomes.
  • Ensure all studies are conducted with ethical approval and patient safety as top priority.
  • Support translational research by bridging clinical practice and scientific innovation.
  • Promote continuous medical advancement through research excellence.

Types of Trials Conducted

Our consultancy supports multiple types of clinical research:

Phase I Trials

First-in-human studies assessing safety and dosage.

Phase II Trials

Focused on drug effectiveness and short-term side effects.

Phase III Trials

Large-scale studies comparing new treatments with standard ones.

Phase IV (PMS)

Post-Marketing Surveillance monitoring long-term safety after approval.

Observational & IIS

Investigator-Initiated Studies led by clinicians under ethical supervision.

Regulatory & Ethical Compliance

All clinical research activities are conducted in strict compliance with global and national standards. Each trial undergoes thorough ethical review, informed consent, and data confidentiality protocols.

  • NABH Accreditation Standards (2022)
  • ICMR Ethical Guidelines
  • ICH-GCP Guidelines
  • CDSCO / DCGI Regulations
  • Institutional Ethics Committee (IEC) Approvals
Ethical Integrity

NABH Alignment for Clinical Trials

NABH compliance ensures every trial is ethical, transparent, and scientifically sound.

NABH Standard Focus Area Objective
REC (Research & Ethics) Formation of IEC Ensures ethical review and patient rights protection.
PRE (Patient Rights) Informed Consent Protects autonomy, privacy, and voluntary participation.
IMS (Info Management) Data Accuracy Secure and compliant record-keeping of research data.
CQI (Quality Improvement) Review & Audit Ensures adherence to ethical and safety standards.

Our Clinical Research Services

01

Site Management

Clinical Trial Site Setup and complete management.

02

Staff Training

Principal Investigator & Research Staff Training.

03

Regulatory Submission

Document preparation and submission to regulators.

04

Ethics Liaison

Ethics Committee Liaison and Approval Support.

05

Data Management

Data Management and Statistical Analysis.

06

Audit Readiness

Post-trial Follow-up and Audit Readiness.

Ethics and Patient Safety

We follow a zero-compromise policy on patient rights and safety. Each participant is:

Fully informed about the study’s purpose, risks, and benefits.

Provided with informed consent forms in understandable language.

Guaranteed confidentiality of all personal and medical data.

Free to withdraw participation at any stage without affecting care.

Monitored by the Institutional Ethics Committee (IEC) continuously.

Our Research Philosophy

“Innovation with Integrity — advancing healthcare through ethical science.”

We believe that clinical research is not just about developing new treatments, but about improving lives through responsible innovation.

Committed to Clinical Excellence & Patient Safety

Start Your Research Journey